Van Plew Daniel P sold REGN
February 14, 2024 · Form 4 insider transaction
Van Plew Daniel P sold 439 shares of Regeneron Pharmaceuticals, Inc. at $937.94 per share, a transaction worth $411.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
439
Price
$937.94
Total value
$411.8K
InsiderVan Plew Daniel P
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 14, 2024
Filing dateFebruary 16, 2024
Shares owned after30,373
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents volume-weighted average price of sales of 439 shares of Company stock on February 14, 2024 at prices ranging from $937.86 to $937.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.